Names, names and names | Cross organon vs. premature pregnancy, pushes hard in medicine for women and nodal Mexico – El Sol de México

A firm that in mid-2021 stole spotlights in the pharmaceutical field was Organon, a spin-off from Merck with a portfolio geared towards women’s health needs.

The multinational headed by Kevin Ali With a presence in 194 countries, 11,000 employees and revenues of 6,500 million dollars, it has here the most important emerging market in a group that includes Russia, Africa, the Middle East and AL. In fact, one of its 6 global plants is located in Xochimilco, with a staff of 350 employees, which even exports to LA, the Caribbean, Canada, the Philippines, Australia and South Africa.

The rudder in Mexico takes him Fernando Fogarina 49-year-old Argentine executive, 28 of them in the pharmaceutical industry, with aggressive plans for the firm to grow double digits in the long term.

Nearshoring opens up manufacturing opportunities and the FDA is already certifying its plant to export to the US.

In addition, it will soon bring a package of biosimilars for rare diseases and there are alliances that are brewing with small laboratories to add innovation. In 2024 a device will be brought for postpartum hemorrhage, a serious cause of mortality. A product to remedy endometriosis is also in the research phase.

Organon, in addition to a robust package of contraceptive products, including a subdermal implant that protects for up to 3 years and eventually up to 5, also manages a line of cardiological, dermatological, respiratory and pain medicines.

A key issue in its strategy is being able to contain premature pregnancy, a serious problem in young people between the ages of 18 and 25 with rates that place us in last place in the OECD with 42 events per thousand. The Netherlands is at 4 x thousand.

with health of Jorge Alcocer It has sought to interact so that with the IP and NGO’s there are better results. No luck. Better has walked with governments like Jalisco and Yucatan. In CDMX there is a program with Xochimilco in charge of Jose Carlos Acosta to promote preventive education. The UN Population Fund, Conapo and Injuve participate.

The demarcation was chosen because its plant is there and the level of pregnancies reaches 81 per thousand, one of the highest in the country. The achievements will be seen later and the effort would be replicated in the context of an avant-garde public policy in Mexico with free and portability.

As you want, a pharmacist who will not be lost sight of.

AUDI ACHIEVES MULTI-YEAR AGREEMENT AND VOTE TOMORROW

It turns out that the automotive Audi that drives Tarek Mashhour reached an agreement with his union on the revision of the collective contract. Given the investment projects at the door, the German company required certainty. It was a four-year deal with inflation plus one point salary increases, plus a robust benefits package. The vote is missing tomorrow. The expectations are favorable.

MEXICAN TOURISM ABROAD STILL BELOW 2019

Despite the improvement in tourism, that of Mexicans abroad by air continues until October 12% below the 2019 level, according to Cicotur statistics that leads Francis Madrid. Obviously the rise in air fares has made many destinations prohibitive, beyond the strength of the peso. Add the loss of purchasing power.

BANXICO’S TURN TODAY AND RISE RATES IN 2023

Everything is ready for Banxico to victoria rodriguez today raise rates by 50 basis points, which will close the year at 10.50%. Yesterday the Fed of Jerome Powell it also raised revenues at the same rate as expected. In 2023 the increases will continue. Here to reach at least 11% and in the US up to 5%, a very high level for that economy.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.